Revenue Capture Accuracy for Infectious Disease Practices

Reconciliation in billing is the process of comparing billed services and expected reimbursement with payments actually received. For an infectious disease practice, this may include reviewing drug, infusion administration, evaluation and management, and consult claims. The comparison can reveal short-pays, incorrect fee schedule application, missing units, NDC mismatches, unpaid balances, or other differences that require follow-up.

Medical billing reconciliation generally involves gathering claim, payment, contract, and account information; matching payments to the related services; comparing reimbursement with contractual expectations; identifying variances; researching their cause; and documenting corrective action. In infectious disease, the review may separate drug, administration, E/M, infusion, and consult activity so practices can distinguish payer errors from charge capture, coding, authorization, or documentation issues.

Revenue leakage can be identified by reviewing the path from referral and documentation through charge capture, claim submission, payment, denial follow-up, and collections. Reporting by payer, service line, and provider can expose under-leveled visits, uncaptured drug or administration charges, recurring denials, unpursued balances, and contract payment differences. The goal is to trace each gap to a specific workflow or reimbursement cause.

A focused review may include drug, infusion administration, evaluation and management, hospital consult, and complex outpatient claims. Practices can compare the billed service, units, coding, NDC information, payer benefit, contract terms, and payment received. This helps identify short-pays, incorrect fee schedule application, unit mismatches, and other issues that may affect the balance sheet.

Authorization is a financial control because coverage requirements can determine whether an infusion, OPAT course, or specialty drug is reimbursable. Support may include verifying eligibility and benefits, determining whether therapy falls under a medical or pharmacy benefit, and tracking requests through resolution. Strong authorization workflows help reduce avoidable denials and the risk of unreimbursed drug costs.

Yes. Effective denial management looks beyond individual claim corrections. Denials can be categorized by root cause, such as drug and administration coding, missing authorization, medical-versus-pharmacy benefit confusion, or under-documented consults. Payer-specific appeals can then be supported by clinical documentation, while findings are shared with clinical, coding, and front-office teams to reduce repeat issues.

Revenue-cycle consulting can review the workflow from referral to final payment, including documentation, coding, eligibility, prior authorization, drug acquisition, infusion billing, denials, underpayments, accounts receivable, and payer or hospital coverage agreements. The outcome is a practical, prioritized view of where revenue is lost, delayed, or left uncollected and what operational changes may address each gap.

Aging accounts receivable can be reviewed by payer, service type, and balance, with particular attention to high-dollar drug, infusion, hospital consult, and complex outpatient claims. Follow-up should document each payer touch and the reason a claim remains unresolved. Grouping stalled claims by cause can help the practice address systemic issues rather than treating every aging balance as an isolated problem.